← Evidence map

ArticleTurkish journal of urology2014

The use of primary and secondary doxazosin XL (8 mg) in the treatment of benign prostate hyperplasia: Is there a new approach in the event of alpha-blocker failure?

Muhammet İhsan Karaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The use of primary and secondary doxazosin XL (8 mg) in the treatment of benign prostate hyperplasia: Is there a new approach in the event of alpha-blocker failure? | OpenQuestion